131I-apamistmab
AAAV1172
Phase 1 small_molecule active
Quick answer
131I-apamistmab for Sickling Disorder Due to Hemoglobin S is a Phase 1 program (small_molecule) at Actinium Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Actinium Pharmaceuticals
- Indication
- Sickling Disorder Due to Hemoglobin S
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active